Name: Tarsus Pharmaceuticals, Inc. (TARS) Balance Sheet
Creator: FinSpry

Tarsus Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Tarsus Pharmaceuticals, Inc. (TARS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	94.82	224.95	71.66	171.33	168.13
Short-Term Investments	196.56	2.50	145.37	0.48	0.00
Cash & Short-Term Investments	291.38	227.44	217.03	171.82	168.13
Accounts Receivable	48.06	16.62	3.58	0.09	0.02
Inventory	2.62	3.11	0.00	0.00	0.00
Other Current Assets	14.65	7.87	4.77	4.05	2.49
Total Current Assets	356.71	256.13	225.38	175.95	170.66
Non-Current Assets
Property, Plant & Equipment (Net)	2.87	3.35	1.53	1.83	1.24
Long-Term Investments	3.00	0.86	0.48	0.66	0.00
Intangible Assets	8.33	3.87	0.00	0.00	0.00
Other Non-Current Assets	6.09	1.51	0.48	0.46	0.08
Total Non-Current Assets	20.29	9.36	2.49	2.96	0.00
Total Assets	376.99	265.49	227.86	178.91	171.97
Current Liabilities
Accounts Payable	27.74	17.77	5.50	2.86	2.24
Short-Term Debt	0.61	0.00	0.00	0.00	0.00
Accrued Liabilities	19.14	18.11	9.21	7.26	2.87
Deferred Revenue	0.00	0.00	0.00	0.70	0.00
Other Current Liabilities	33.12	4.87	5.52	2.80	0.00
Total Current Liabilities	80.61	36.94	15.43	11.48	5.39
Non-Current Liabilities
Long-Term Debt	71.85	29.82	19.43	0.59	0.00
Other Non-Current Liabilities	0.00	1.75	0.10	0.11	0.06
Total Non-Current Liabilities	71.85	31.57	19.53	0.70	0.00
Total Liabilities	152.46	68.50	34.96	12.18	5.99
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.00	0.00
Retained Earnings	-360.21	-244.66	-108.76	-46.67	-32.85
Accumulated Other Comprehensive Income	0.18	0.00	-0.07	0.00	0.00
Additional Paid-in Capital	584.56	441.64	301.73	213.40	0.00
Shares Outstanding	38.35	34.21	26.73	20.70	0.00
Total Stockholders' Equity	224.53	196.99	192.90	166.73	165.98
Total Liabilities & Equity	376.99	265.49	227.86	178.91	0.00